series-b
Stage
1
Investors
About
Tenpoint Therapeutics develops innovative therapies for age-related eye diseases, including presbyopia, cataracts, and geographic atrophy, with a focus on restoring vision through regenerative medicine and novel treatments.
Explore Tenpoint Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.